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Presentation of virus-derived antigenic peptides by major histocompatibility (MHC) class I molecules directs CD8
+ T-cell lysis of infected cells, which plays a key role in clearance of many viruses (1) . The human herpesviruses have nonetheless evolved the ability to establish lifelong infection. Greater than 50% of the world's population carry the β-herpesvirus HCMV, which has become an important opportunistic pathogen (2) . Persistent infection is remarkable, as To enable persistent infection, the cytomegaloviruses have evolved numerous mechanisms to subvert the immune response, including disruption of the MHC class I antigen presentation pathway (4).
A cluster of immunomodulatory genes are located in the unique short (US) region of the HCMV genome, comprising the US2, US6 and US11 families (5) .
These encode a series of eight glycoproteins, at least four of which interfere with cell surface expression of MHC class I molecules. Each possess an ER-lumenal domain, a single predicted transmembrane domain, and a short cytoplasmic tail.
US3 retains class I molecules in the ER by blocking transport of folded class I complexes to the Golgi during the immediate early period of virus infection (6) (7) (8) .
US2 and US11 independently target ER-to-cytosol dislocation of class I during early periods of virus infection (9, 10) . US6 blocks the TAP peptide transporter from the ER-lumenal side during late periods of virus infection (11) (12) (13) . The concerted action of this series of HCMV immuno-evasive proteins is believed to diminish CD8+ T cell recognition of HCMV peptide antigens. Indeed, it has been difficult to identify cytotoxic T lymphocytes specific for most HCMV protein epitopes (14) .
Adenovirus, herpes simplex viruses, HIV and Kaposi's sarcoma-associated herpesvirus encode factors that specifically down-modulate human class I expression (4, 15) . While a growing number of such proteins have been described, little is known about the structural basis for interaction with their target proteins.
Here we report the structure of the soluble complex between US2 and HLA-A2, the first structure of a viral protein that down-regulates class I. We find that US2
contains an Ig-like fold, and using structure-based sequence alignments, we predict that seven other HCMV US proteins are folded similarly. This structure also has implications for the mechanism by which US2 targets class I for proteasome degradation.
Materials and Methods
Protein Refolding and Purification. US2 15-140 was refolded as described previously (16) Structure Determination and Refinement. The structure was determined by molecular replacement in CNS (17) using free HLA-A2/Tax as a search model (18) .
Cross-rotation and translation functions identified four different solutions, one for each complex in the asymmetric unit. Refinement was carried out using CNS version 0.9. Model building was performed in O (19) using a solvent-flattened four-fold averaged map. Strict non-crystallographic symmetry (NCS) constraints between the four US2 15-140 /HLA-A2/Tax complexes were utilized for the first three rounds of refinement. For the final four rounds of refinement, NCS restraints of weight 300 were maintained. The refined atomic model consists of four copies each of HLA-A2 residues Gly1-Glu275, β 2 -microglobulin residues Met0-Met99, Tax peptide residues 1-9, US2 residues Pro43-Leu137; and 1,446 water molecules.
Buried molecular surface area and inter-atom contacts were calculated using AREAIMOL and CONTACT, respectively (CCP4). Figures were generated using
Ribbons (20) . were maintained and used for pulse-chase experiments as described (10) .
Mutagenesis of
Procedures for NP-40 lysis and immunoprecipitation have been described (9, 10) .
Results and discussion
Structure Determination. US2 is a 199-residue protein whose ER-lumenal domain is predicted to span residues 1-164. The core (residues 15-140) of the US2 ERlumenal domain was expressed in E. coli and refolded in vitro in the presence of recombinant the HLA-A2/human T lymphotropic virus type I Tax peptide complex (16) . The crystal structure of the US2/HLA-A2/Tax-peptide complex was determined to 2.2 Å resolution (see Materials and Methods). Table 1 shows the data collection and refinement statistics. The current model includes all residues of HLA-A2/Tax and residues 43-137 of US2 (Fig. 1A) . Terminal US2 residues 15-42
and 138-140 are likely flexible or unstructured, since no electron density was observed for these residues, although US2 ( Fig. 2D) . Thus, in vivo, US2 binds class I molecules at the larger binding site 1, and this interaction is required for subsequent dislocation of class I heavy chains.
The face of one β-sheet of US2 (C'CFG) makes extensive contacts with HLA-A2 in binding site 1 (Fig. 2B, 3 While not essential for replication in vitro, four genes in this cluster alter cell surface expression of class I molecules (4) . By aligning the sequences of HCMV US proteins based on the US2 structure (Fig. 1C) , each of these viral proteins appears to contain an Ig-like fold similar to US2, suggesting that these three gene families arose by duplication from an ancestral Ig-like fold-encoding gene (Fig. 1C) (37) .
Alignment with US2 reveals conservation of the non-canonical disulfide bond and many core hydrophobic amino acids, particularly in the central β-strands B and F.
Based on the US2 structure, all predicted glycosylation sites would be on outer surfaces. Since many Ig-like folds mediate adhesion to other protein surfaces, it is likely that the US3 and US11 Ig domains dictate association with class I. The sequence conservation is too low to predict which surface will be used for these interactions. US7-10 are likewise predicted to be type I membrane glycoproteins whose ER lumenal domains appear to contain Ig-like folds (Fig. 1C) . However, the binding partners of US7-10 are presently unknown.
Human adenovirus encodes a glycoprotein, E3-19K, which retains newly synthesized class I molecules in the ER (38) . Sequence similarity searches reveal significant conservation between E3-19K and immunoglobulin light chains.
However, the putative E3-19K ER-lumenal Ig-fold likely differs from that found in the US genes, since the sequence similarity is insignificant and the location of cysteines is not conserved between E3-19K and the US family proteins.
Comparison of the US2 Interaction to that of other MHC Class I Molecule
Ligands. Crystal structures have now been obtained for MHC class I molecules associated with five of its membrane protein ligands (Fig. 4) : the αβ Τ cell receptor In addition, knowledge of US2 surface residues will allow us to chemically probe the surface environment of US2 via substitution with residues that react with membrane-permeable bifunctional cross-linkers. Such mutants will be an important tool for identification of factors that participate in ER-dislocation. and US11 family members. β-strands (red or blue arrows; letter-labeled as in Fig.   1A and 1B) and US2 residues that contact HLA-A2 (*) are indicated. Conserved hydrophobic residues are blue, predicted N-linked glycosylation sites are orange, and cysteines predicted to form the A to G strand disulfide bond are magenta.
US2 core residues (>90% buried, determined using SPDBV (48) 
